At the news
? BEARISHIMPACT 5/10 144 filed Jul 30, 2026 at 17:39 ET
5AM Ventures V, L.P., an early venture investor and affiliated stockholder of Entrada Therapeutics, filed a Form 144 notice of intent to sell 331,156 shares of common stock, valued at approximately $2.17 million. The proposed sale represents about 0.85% of shares outstanding and signals potential portfolio distribution by a long-term holder.
- 5AM Ventures V, L.P. proposes to sell 331,156 shares of Entrada Therapeutics common stock.
- Estimated market value of the proposed sale is $2,169,072.
- Shares were acquired on October 12, 2016 via venture financing investment.
- The sale is to be executed through Goldman Sachs & Co. LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access